BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2006
View Archived Issues
Kadian effective in treating non-malignant pain
Read More
Statins, NSAIDs and calcium channel blockers linked to reduced melanoma risk
Read More
CycloSal nucleotides may optimize anti-HIV therapy
Read More
Elan offers development updates
Read More
BioMarin highlights positive quarter
Read More
NPY5 receptor antagonist effective in rodent obesity models
Read More
Dextromethorphan/quinidine improves pseudobulbar affect in multiple sclerosis
Read More
HCV peptide vaccine safe and active in randomized study
Read More
AC-100 increases osteogenic activity of BMP2
Read More
Edotecarin enhances in vivo antitumor activity of other treatments
Read More
TorreyPines Therapeutics' tezampanel completes phase I trials for acute migraine
Read More
AstraZeneca strengthens biological therapeutics divisions by making bid on CAT
Read More
Axonyx completes phase I clinical trial with Posiphen
Read More
Jurnista completes European mutual recognition procedure
Read More
EntreMed evaluates Panzem NCD in phase II clinical trial for carcinoid cancer
Read More
Nereus Pharmaceuticals' anticancer proteasome inhibitor enters clinical trials
Read More
BioAlliance Pharma begins pivotal phase III trial of Loramyc for treatment for OPC
Read More
Oxigene's Combretastatin A4P granted orphan drug designation for ovarian cancer
Read More
Pixantrone combination regimen shown effective in relapsed indolent NHL
Read More
New agents for treating thrombosis and related disorders reported in recent patents
Read More
Recent patents disclose novel treatment strategies for cardiovascular disorders
Read More
Favorable phase II results with CVac in ovarian cancer reported
Read More
Recent Pfizer and Scynexis patents report novel therapeutics for HCV infection
Read More
FDA meeting guides accelerated clinical development of PI-88
Read More
Recruitment completed for pivotal phase III alitretinoin trial for severe chronic hand dermatitis
Read More
Basilea's ceftobiprole enters phase III trial for community-acquired pneumonia
Read More
FDA approves Cesamet for cancer chemotherapy-associated nausea and vomiting
Read More
Exelon recommended by FDA Advisory Committee for additional indication
Read More
Hsp90 inhibitor shows activity in a murine model of choroidal neovascularization
Read More
Prodrugs of vidarabine demonstrate activity against vaccinia virus infections
Read More
Protein-based therapy for junctional epidermolysis bullosa shows efficacy in preclinical studies
Read More